According to PAVmed 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.58. At the end of 2024 the company had a P/S ratio of 2.39.
Year | P/S ratio | Change |
---|---|---|
2024 | 2.39 | -82.3% |
2023 | 13.5 | -88.66% |
2022 | 119 | -72.42% |
2021 | 433 | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A |